Prolonged and profound acid inhibition is crucial in Helicobacter pylori treatment with a proton pump inhibitor combined with amoxicillin

Scandinavian Journal of Gastroenterology

Volumn 33, Issue 1, 1998, Pages 39-43

  Sjostedt S ^a   Sagar, M ^a   Lindberg, G ^a   Wikstrom B ^a   Nord, C E ^a   Seensalu, R ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amoxicillin; Gastric acid secretion; Gastrins; Helicobacter pylori; Omeprazole

Indexed keywords

AMOXICILLIN; GASTRIN; OMEPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; ERADICATION THERAPY; ETHNIC GROUP; FEMALE; GASTRIN RELEASE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; MEAL; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; STOMACH ACID SECRETION; STOMACH PH; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PROTON PUMPS; SEX FACTORS; TREATMENT OUTCOME;

EID: 0031952644     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/00365529850166185     Document Type: Article

References (15)

1. Soll AH, for the practice parameters committee of the American College of Gastroenterology. Medical treatment of peptic ulcer disease. Practice guidelines. JAMA 1996;275:622-9.
2. Gad A, Unge P. Antibacterial therapy of Helicobacter pyloriassociated peptic ulcer disease: a new strategy [editorial]. J Clin Gastroenterol 1994;19:6-10.
3. Axon ATR. The role of acid inhibition in the treatment of Helicobacter pylori infection. Scand J Gastroenterol 1994;29 Suppl 201:16-23.
4. McGowan CC, Cover TL, Blaser MJ. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism. Gastroenterology 1994;107: 738-43.
5. McNulty CAM. Bacteriological and pharmacological basis for the treatment of Campylobacter pylori infection. In: Rathbone BJ, Heatley RV, editors. Campylobacter pylori and gastroduodenal disease. Oxford: Blackwell Scientific Publications; 1989. p. 209-16.
6. Labenz J, Stolte M, Blum AL, Jorias I, Leverkus F, Sollböhmer M, et al. Intragastric acidity as a predictor of the success of Helicobacter pylori eradication: a study in peptic ulcer patients with omeprazole and amoxicillin. Gut 1995;37:39-43.
7. Gad A. Campylobacter pylori and gastroduodenal disease. Clinical and morphological correlations. In: Bertaccini G, Cheli R, Dobrilla G, editors. The duodenum. Cortina: International Raven Press; 1988. p. 119-30.
8. Sjöstedt S, Kager L, Veress B, Nord CE. Campylobacter pylori in relation to other aerobic and anaerobic microorganisms in patients with gastric disease. Microb Ecol Health Dis 1989; 2:107-14.
9. Nilsson G. Increased plasma gastrin levels in connection with inhibition of gastric acid responses to sham feeding following bulbar perfusion with acid in dogs. Scand J Gastroenterol 1975; 10:273-7.
10. Bayerdörffer E, Mannes GA, Sommer A, Höchter W, Weingart J, Hatz R, et al. High dose omeprazole treament combined with amoxicillin eradicates Helicobacter pylori. Eur J Gastroenterol Hepatol 1992;4:697-702.
11. Meyer-Rosberg K, Scott DR, Rex D, Melchers K, Sachs G. The effect of environmental pH on the proton motive force of Helicobacter pylori. Gastroenterology 1996;111:886-900.
12. Unge P, Gad A, Eriksson K, Bergman B, Carling L, Ekström P, et al. Amoxicillin added to omeprazole prevents relapse in the treatment of duodenal ulcer patients. Eur J Gastroenterol Hepatol 1993;5:325-31.
13. Bertilsson L, Lou Y-Q, Du Y-L, Liu Y, Kuang T-Y, Liao X-M, et al. Pronounced differences between native Chinese and Swedish populations in the polymorphic hydroxylations of debrisoquin and S-mephenytoin. Clin Pharmacol Ther 1992;51: 388-97.
14. McColl KEL, Nujumi AM El, Dorrian CA, Macdonald AMI, Fullarton GM, Harwood J. Helicobacter pylori and hypergastrinaemia during proton pump inhibitor therapy. Scand J Gastroenterol 1992;27:93-8.
15. Chittajallu RS, Neithercut WD, Ardill JES, McColl KEL. Helicobacter pylori-related hypergastrinaemia is not due to elevated antral surface pH. Scand J Gastroenterol 1992;27:218-22.